Tiangang Li to Cholesterol
This is a "connection" page, showing publications Tiangang Li has written about Cholesterol.
Connection Strength
0.687
-
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021; 12(3):1001-1019.
Score: 0.687